SCC Making News: OK-born Anti-Cancer Drug Moves to Clinical Trials

Preventing ovarian cancer with a capsule might sound impossible to many, but not to Doris M. Benbrook, Ph.D. at the University of Oklahoma Health Sciences Center. It is research, though, not magic that has led her team to the development of a potential cancer prevention drug in capsule form. Now with a new multi-million dollar grant from the National Cancer Institute, Benbrook and her team will launch the first-in-human trial of their Oklahoma-developed compound at the Stephenson Cancer Center. In laboratory models, the compound halted ovarian cancer before it could start, and without causing side effects.